Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05357378 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the HIT Reverse HRS
A NA study of Osteoarthritis, Hip and Degenerative Joint Disease, sponsored by Hip Innovation Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 6
- Study locations
NCT05357378 is a NA study of Osteoarthritis, Hip and Degenerative Joint Disease that is actively recruiting participants, run by Hip Innovation Technology. The registered enrollment target is 288 participants, below the 1,259-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (77% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT05357378, a NA study of Osteoarthritis, Hip and Degenerative Joint Disease, is actively recruiting participants, sponsored by Hip Innovation Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Conditions Studied
Interventions
- DEVICE Hip Innovation Technology Reverse Hip Replacement System
- DEVICE Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.
Study Locations (6)
Florida
- Miami Institute for Joint Reconstruction - Miami
- Advent Health Hospital, Carrollwood - Tampa
- Tampa General Health / Florida Orthopedic Institute - Tampa
Maryland
- LifeBridge Health Rubin Institute for Advanced Orthopedics - Baltimore
New Jersey
- Division of Orthopaedic Surgery - Somers Point
Ohio
- JIS Orthopedics - New Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2035-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05357378
The ClinicalTrials.gov registry entry for NCT05357378 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (77% lower). The listed sponsor is Hip Innovation Technology, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 2 interventions - of which Hip Innovation Technology Reverse Hip Replacement System is the first listed.
NCT05357378 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, Maryland, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05357378 about?
NCT05357378 is a clinical study titled "Safety and Effectiveness of the HIT Reverse HRS". The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
What is the current status of trial NCT05357378?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2022-07-15. Estimated completion is 2035-07-15.
What conditions does trial NCT05357378 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Degenerative Joint Disease, Avascular Necrosis of Hip, Traumatic Arthropathy-Hip.
What interventions are being tested in trial NCT05357378?
The interventions under investigation include: Hip Innovation Technology Reverse Hip Replacement System (DEVICE), Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. (DEVICE).
Who is sponsoring clinical trial NCT05357378?
This trial is sponsored by Hip Innovation Technology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05357378 being conducted?
This trial has 6 study locations across Florida, Maryland, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.